If you’re managing psoriasis alongside obesity or type 2 diabetes, you already know how much these conditions can influence each other. A difficult stretch with your skin can affect your energy, your confidence, and your overall health — and managing two chronic conditions at once takes real effort.
Here’s something that may be encouraging: medications originally developed for metabolic conditions are showing real promise for people with psoriasis. This guide explains what we currently know, what it might mean for you, and how to have an informed conversation with your care team.
For a long time, doctors viewed obesity as something that simply tended to occur alongside psoriasis. Now we understand the relationship runs much deeper.
Excess body fat doesn't just sit passively in the body — it actively produces inflammatory signals. These signals add to the same type of body-wide inflammation that drives psoriasis flares. At the same time, severe psoriasis can affect the way your body processes insulin, which may raise your risk for metabolic conditions like type 2 diabetes.
In other words, the two conditions can fuel each other. That's why treating the whole picture — not just the skin — can make such a meaningful difference.
GLP-1 medications are a class of medications that work by mimicking a natural hormone in the body. They're widely used to treat type 2 diabetes and obesity by helping regulate blood sugar and appetite. But researchers and dermatologists have started noticing something interesting: many people on these medications also see their psoriasis improve. There appear to be two reasons for this.
GLP-1 medications help many people lose a significant amount of weight. As body fat decreases, so does the baseline level of inflammation in the body — which may make it easier for existing psoriasis treatments to work and for skin to stay clearer between flares.
Perhaps most interesting is that some people report their psoriasis improving before they've lost much weight at all. This suggests GLP-1 medications may have a more direct effect on the immune system — potentially calming some of the same inflammatory signals that cause psoriatic plaques to form. Research in this area is still ongoing, but the early findings are encouraging.
We're still in the early stages of understanding exactly how GLP-1 medications affect psoriasis — large dedicated clinical trials are still underway. But the real-world data collected so far is consistent and promising.
GLP-1 medications are not currently FDA-approved as treatments for psoriasis. But, if you're already managing psoriasis alongside obesity or type 2 diabetes, they may be a meaningful part of your broader care plan and may even help you take less of your psoriasis medications.
A few things worth knowing before you bring it up with your care team:
Curious whether a GLP-1 medication might make sense for your situation? Reach out through your Zest portal — your care team is here to think it through with you.
Managing psoriasis and a metabolic condition at the same time is genuinely hard — and it's worth knowing that new tools are emerging that may help with both at once.
GLP-1 medications represent a promising and evolving area of research for people living with psoriasis, particularly those also managing weight or blood sugar. At Zest, we stay close to the latest evidence so we can help you make informed decisions about your care.You’re never navigating this alone — reach out anytime.